Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAIN: Neoadjuvant Gemcitabine + Cisplatin in IGBC/BTC
NCT03673072Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Jul 2019
- Primary completion
- Oct 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132) in gallbladder carcinoma, biliary tract cancer (BTC), sponsored by Krankenhaus Nordwest. Started Jul 2019; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
gallbladder carcinomabiliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03673072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673072.